Cargando…
APP21 transgenic rats develop age-dependent cognitive impairment and microglia accumulation within white matter tracts
BACKGROUND: Most of the animal models commonly used for preclinical research into Alzheimer’s disease (AD) largely fail to address the pathophysiology, including the impact of known risk factors, of the widely diagnosed sporadic form of the disease. Here, we use a transgenic rat (APP21) that does no...
Autores principales: | Weishaupt, Nina, Liu, Qingfan, Shin, Sheojung, Singh, Ramandeep, Agca, Yuksel, Agca, Cansu, Hachinski, Vladimir, Whitehead, Shawn Narain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114740/ https://www.ncbi.nlm.nih.gov/pubmed/30153843 http://dx.doi.org/10.1186/s12974-018-1273-7 |
Ejemplares similares
-
Hypertension and Pathogenic hAPP Independently Induce White Matter Astrocytosis and Cognitive Impairment in the Rat
por: Levit, Alexander, et al.
Publicado: (2020) -
White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer’s disease rat model
por: Ivanova, Nadezda, et al.
Publicado: (2020) -
Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease
por: Klakotskaia, Diana, et al.
Publicado: (2018) -
Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically
por: Agca, Cansu, et al.
Publicado: (2008) -
Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP
por: Silverberg, Gerald D, et al.
Publicado: (2015)